Facilitated By

San Antonio Medical Foundation

News

  • Intensity Therapeutics Shares Rise On Positive Phase 2 INVINCIBLE Trial Data Of INT230-6

    This data was presented during the 2023 San Antonio Breast Cancer ... Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor. Biotech ...

  • MEDSIR presents promising results at SABCS 2023: ATRACTIB and DEBBRAH trials ... - BioSpace

    ... San Antonio Breast Cancer Symposium (SABCS) that have the potential to ... Biotech Bay · Biotech Beach · BioCapital · BioMidwest · Bio NC · BioForest ...

  • T-DM1 Falls Short in Elderly Patients With Advanced, HER2+ Breast Cancer

    ... San Antonio Breast Cancer Symposium 2023. T-DMI failed to show non ... Disclosures: Dr Shimomura declared affiliations with biotech, pharmaceutical, and ...

  • Track 20 of San Antonio's major construction projects

    University Health is building a hospital near Texas A&M University-San Antonio. ... San Antonio biotech group to anchor East Side development ⤍.

  • Ribometrix Demonstrates Rapid Progress for eIF4E Program at San Antonio Breast Cancer ...

    — Ribometrix, a biotechnology company developing small molecule therapeutics that modulate RNA biology ... San Antonio Breast Cancer Symposium (SABCS), ...